Embla Medical hfOSSFF 92 Net Margin % is 6.22% as of Mar. 2026, which is 30% below its 10-year median of 8.94. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Embla Medical hf ranks better than 69.65% on this metric.
The historical rank and industry rank for Embla Medical hf's Net Margin % or its related term are showing as below:
OSSFF'
s Net Margin % Range Over the Past 10 Years
Min: 0.99 Med: 8.94 Max: 13.01
Current: 8.93
OSSFF's Net Margin % is ranked better than 69.65% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.07
vs OSSFF: 8.93
Embla Medical hf (OTCPK:OSSFF) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Embla Medical hf Net Margin % Related Terms
Embla Medical hf Net Margin % Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Net Margin % distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Net Margin % of 6.22% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Embla Medical hf and its competitors. This is 30% below median its historical median of 8.94. Over the past decade, Embla Medical hf's Net Margin % has ranged from 0.99 to 13.01. According to the industry distribution chart, Embla Medical hf ranks #248 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 30.4%.
Is Embla Medical hf's Net Margin % too high?
Embla Medical hf's current Net Margin % of 6.22% is 30% below median its 10-year median of 8.94. Over the past 10 years, this metric has ranged from a low of 0.99 to a high of 13.01. The Medical Devices & Instruments industry median Net Margin % is 2.07. Embla Medical hf's value of 6.22% is 200.5% above this industry median. Based on the distribution chart, Embla Medical hf ranks #248 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #248 out of 817 companies for Net Margin %. This puts Embla Medical hf in the upper half of its industry. The industry median Net Margin % is 2.07. Embla Medical hf's value of 6.22% is 200.5% above this benchmark. Historically, Embla Medical hf's own Net Margin % has ranged from 0.99 to 13.01 over the past decade. While the company's 10-year median is 8.94 vs. the industry median of 2.07, Embla Medical hf has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.07, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Net Margin % of 6.22% is 200.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Net Margin % is 6.22%, which is 30% below median its own 10-year median of 8.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Net Margin % of 6.22%. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current Net Margin % is 6.22%, which is 30% below median its 10-year median of 8.94 and 200.5% above the Medical Devices & Instruments industry median of 2.07. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Net Margin % is 6.22% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.
Key valuation signals for OSSFF:
Net Margin %: 6.22% (30% below median its 10-year median of 8.94)
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
Industry Position: 200.5% above the Medical Devices & Instruments median (#248 of 817)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
